1-3 of 3
Aziz Zaanan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)

Fanny Garlan, Pierre Laurent-Puig, David Sefrioui, Nathalie Siauve, Audrey Didelot, Nasrin Sarafan-Vasseur, Pierre Michel, Geraldine Perkins, Claire Mulot, Hélène Blons, Julien Taieb, Frederic Di Fiore, Valerie Taly, Aziz Zaanan
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (18): 5416–5425.
https://doi.org/10.1158/1078-0432.CCR-16-3155
Published: 14 September 2017
View articletitled, Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)
Open the PDF for Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study) in another window
Includes: Supplementary data
Journal Articles

Colon Cancer Mutation: Prognosis/Prediction–Letter

Aziz Zaanan, Franck Bonnetain, Franck A. Sinicrope, Pierre Laurent-Puig, Julien Taïeb
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (5): 1300.
https://doi.org/10.1158/1078-0432.CCR-12-3765
Published: 03 March 2013
View articletitled, Colon Cancer Mutation: Prognosis/Prediction–Letter
Open the PDF for Colon Cancer Mutation: Prognosis/Prediction–Letter in another window
Journal Articles

Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy

Aziz Zaanan, Jean-François Fléjou, Jean-François Emile, Guetz Gaëtan Des, Peggy Cuilliere-Dartigues, David Malka, Cédric Lecaille, Pierre Validire, Christophe Louvet, Philippe Rougier, Aimery de Gramont, Franck Bonnetain, Françoise Praz, Julien Taïeb
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (23): 7470–7478.
https://doi.org/10.1158/1078-0432.CCR-11-1048
Published: 30 November 2011
View articletitled, Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy
Open the PDF for Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy in another window
Includes: Supplementary data